Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 25, 2022	Dec. 26, 2021	Dec. 27, 2020
Operating activities
Net income before attribution to noncontrolling interests	$ 69,349	$ 124,955	$ 60,614
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (benefit) for allowance for credit losses on accounts and notes receivable	20,539	(852)	(4,734)
Depreciation and amortization	52,032	48,816	49,705
Refranchising and impairment loss	12,065	0	0
Deferred income taxes	2,798	3,753	(9,268)
Stock-based compensation expense	18,388	16,919	16,310
Other	1,056	581	2,257
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(29,167)	4,023	(22,420)
Income tax receivable	586	(8,113)	3,760
Inventories	(7,496)	(4,708)	(2,736)
Prepaid expenses and other current assets	5,587	2,866	2,884
Other assets and liabilities	(13,458)	(20,077)	20,879
Accounts payable	(8,350)	(9,278)	8,229
Income and other taxes payable	(10,710)	9,733	2,664
Accrued expenses and other current liabilities	4,846	15,875	59,353
Deferred revenue	(257)	182	(1,058)
Net cash provided by operating activities	117,808	184,675	186,439
Investing activities
Purchases of property and equipment	(78,391)	(68,559)	(35,652)
Notes issued	(9,296)	(16,132)	(16,589)
Repayments of notes issued	13,045	18,555	11,154
Acquisitions, net of cash acquired	(1,219)	(699)	0
Proceeds from refranchising, net of cash transferred	13,588	0	0
Other	(520)	3,323	16
Net cash used in investing activities	(62,793)	(63,512)	(41,071)
Financing activities
Proceeds from issuance of senior notes	0	400,000	0
Net proceeds of revolving credit facilities	115,000	80,000	0
Debt issuance costs	0	(9,179)	0
Proceeds from exercise of stock options	4,036	11,969	30,622
Repurchase of Series B Convertible Preferred Stock	0	(188,647)	0
Acquisition of Company common stock	(125,000)	(72,499)	(2,701)
Dividends paid to common stockholders	(54,767)	(40,356)	(29,362)
Dividends paid to preferred stockholders	0	(6,394)	(13,649)
Tax payments for equity award issuances	(9,546)	(5,847)	(3,974)
Distributions to noncontrolling interests	(1,211)	(5,942)	(2,420)
Repayments of term loan	0	(340,000)	(20,000)
Other	(4,752)	(3,631)	(1,977)
Net cash used in financing activities	(76,240)	(180,526)	(43,461)
Effect of exchange rate changes on cash and cash equivalents	(2,012)	(231)	386
Change in cash and cash equivalents	(23,237)	(59,594)	102,293
Cash and cash equivalents at beginning of period	70,610	130,204	27,911
Cash and cash equivalents at end of period	$ 47,373	$ 70,610	$ 130,204